Nkarta is a biopharmaceutical company that develops and commercializes natural killer cell therapies for the treatment of cancer.
Business Model:
Revenue: $115.4k
Employees: 51-200
Address: 6000 Shoreline Court
City: South San Francisco
State: CA
Zip: 94080
Country: US
Nkarta is a biopharmaceutical company that develops and commercializes natural killer cell therapies for the treatment of cancer.
Contact Phone:
+14155824923
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/10/2020
IPO Valuation:
$548M
Ticker Symbol:
NKTX
IPO Price:
$18/share
Amount Raised:
$252M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2019 | Series B | 9 | $114M |
Amgen Ventures Deerfield Life Sciences Partners Logos Capital New Enterprise Associates Novo Holdings RA Capital Management Samsara BioCapital SR One Amgen Ventures Deerfield Life Sciences Partners Logos Capital New Enterprise Associates Novo Holdings RA Capital Management Samsara BioCapital SR One |
1/2015 | Series A | 3 | $11M |
New Enterprise Associates Novo Holdings SR One New Enterprise Associates Novo Holdings SR One |
12/2014 | Series A | $11M | 4/2022 | Post-IPO Equity | - | 7/2020 | IPO | $252M |
|
4/2022 | Post-IPO Equity | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|